Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy

Table 2

Correlation between CEA levels and clinicopathological factors at initial diagnosis.

Factor	CEA value ng/mL ()	Univariate analysis		Multivariate analysis
		Age
≤57		8.872	0.004	1.344	0.250
> 57
Menstruation
Yes		6.702	0.011	0.263	0.609
No
Comorbidities
No		11.348	0.001	4.819	0.031
Yes
BMI
≤24		0.865	0.355
>24
Tumor size
≤2 cm		1.935	0.168
>2 cm
Nodal status
0		3.597	0.032	3.260	0.043
1-3
≥4
HR status
Positive		2.787	0.099
Negative
ALT at initial diagnosis
≤15		3.806	0.054
>15
AST at initial diagnosis
≤20		5.283	0.024	1.781	0.186
>20
rGT at initial diagnosis
≤16		0.024	0.876
>16
Triglycerides at initial diagnosis
≤1.09		0.608	0.438
>1.09
Cholesterol at initial diagnosis
≤4.62		0.264	0.609
>4.62
Fasting blood glucose at initial diagnosis
≤4.88		2.228	0.139
>4.88
WBC at initial diagnosis
≤6.27		0.028	0.867
>6.27
NEUT at initial diagnosis
≤3.50		0.061	0.805
>3.50
MONO at initial diagnosis
≤0.29		0.039	0.844
>0.29
LY at initial diagnosis
≤1.95		3.182	0.078
>1.95
PLT/LY at initial diagnosis
≤117.54		6.057	0.016	2.423	0.123
>117.54
NEUT/LY at initial diagnosis
≤1.74		0.118	0.732
>1.74
LY/MONO at initial diagnosis
≤6.61		2.338	0.130
>6.61
SII at initial diagnosis
≤410.69		1.776	0.186
>410.69